BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 22, 2003
View Archived Issues
High doses of interferon beta-1b effective in early relapsing-remitting MS
Read More
Atorvastatin reduces cardiovascular events in hypertensive patients with average cholesterol levels
Read More
New data on urokinase in intracerebral hematoma
Read More
Protective effects against malaria reported for a novel primaquine analogue
Read More
Antitumor acridine derivatives prepared and tested at Servier
Read More
Three series of IBAT inhibitors identified by AstraZeneca scientists
Read More
Novel glucose-lowering agents in Sankyo research pipeline
Read More
GSK-3beta or dual GSK-3beta/CDK5 inhibitors for use in AD and other disorders
Read More
BMS researchers present new CRF antagonists with utility in anxiety, depression, etc.
Read More
Triapine evaluated clinically in combination with cytarabine for leukemia
Read More
Macrocyclic modulators of c-fos expression and their use in cancer therapy
Read More
Regenecor established to acquire PPL subsidiary
Read More
Genmab reviews developments in 2002
Read More
Gastrointestinal effects of the kappa opioid receptor agonist asimadoline
Read More
A humanized anti-EGFR monoclonal antibody reported safe in advanced epithelial cancer
Read More
Potential use of mozavaptan plus furosemide for treating edema and hyponatremia
Read More
Activa Therapy receives humanitarian device exemption for dystonia
Read More
Ortho-McNeil to acquire Axert marketing rights
Read More
Medarex and Pfizer form antibody development partnership
Read More
Praecis submits IND to begin phase I trial of PPI-2458 in NHL
Read More
GlaxoSmithKline files IND for topotecan TCS
Read More
FDA approves Vigamox
Read More
Achillion and Phytobiotech to discover drugs for infectious disease
Read More
Merger of Pfizer and Pharmacia expected to result in major synergies
Read More
